{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T21:43:27Z","timestamp":1780868607472,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vaccine.2022.04.031","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T01:54:39Z","timestamp":1649728479000},"page":"3389-3394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 \u2013 October 2021"],"prefix":"10.1016","volume":"40","author":[{"given":"Pedro L.","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine K.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Strid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Ellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamma","family":"Mba-Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna","family":"Alimchandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Cragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.04.031_b0005","unstructured":"CDC. Information about COVID-19 Vaccines for People who Are Pregnant or Breastfeeding. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/pregnancy.html"},{"key":"10.1016\/j.vaccine.2022.04.031_b0010","unstructured":"CDC. Science Brief: Evidence used to update the list of underlying medical conditions that increase a person\u2019s risk of severe illness from COVID-19. Scientific Evidence for Conditions that Increase Risk of Severe Illness | COVID-19 | CDC Accessed January 23, 2022"},{"key":"10.1016\/j.vaccine.2022.04.031_b0015","doi-asserted-by":"crossref","unstructured":"Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis BMJ 2020; 370 :m3320 doi:10.1136\/bmj.m3320","DOI":"10.1136\/bmj.m3320"},{"issue":"8","key":"10.1016\/j.vaccine.2022.04.031_b0020","doi-asserted-by":"crossref","first-page":"e2120456","DOI":"10.1001\/jamanetworkopen.2021.20456","article-title":"Characteristics and Outcomes of Women With COVID-19 Giving Birth at US Academic Centers During the COVID-19 Pandemic","volume":"4","author":"Chinn","year":"2021","journal-title":"JAMA Netw Open."},{"key":"10.1016\/j.vaccine.2022.04.031_b0025","unstructured":"Food and Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers): emergency use authorization (EUA) of the PfizerBioNTech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). 2021 (https:\/\/www.fda.gov\/media\/144413\/download) Accessed January 23, 2022"},{"key":"10.1016\/j.vaccine.2022.04.031_b0030","unstructured":"Food and Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers): emergency use authorization (EUA) of the Moderna COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). 2021 (https:\/\/www.fda.gov\/media\/144637\/download). Accessed January 23, 2022"},{"key":"10.1016\/j.vaccine.2022.04.031_b0035","unstructured":"Food and Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers) emergency use authorization (EUA) of the Janssen COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). https:\/\/www.fda.gov\/media\/146304\/download Accessed January 23, 2022"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.031_b0040","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/S2214-109X(20)30484-8","article-title":"Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action","volume":"9","author":"Taylor","year":"2021","journal-title":"The Lancet Global Health"},{"issue":"6","key":"10.1016\/j.vaccine.2022.04.031_b0045","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.vaccine.2020.12.074","article-title":"The need for inclusion of pregnant women in COVID-19 vaccine trials","volume":"39","author":"Beigi","year":"2021","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2022.04.031_b0050","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The Advisory Committee on Immunization Practices\u2019 interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine \u2014 United States, December 2020","volume":"69","author":"Oliver","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5152","key":"10.1016\/j.vaccine.2022.04.031_b0055","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.15585\/mmwr.mm695152e1","article-title":"The Advisory Committee on Immunization Practices\u2019 interim recommendation for use of Moderna COVID-19 vaccine \u2014 United States, December 2020","volume":"69","author":"Oliver","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5152","key":"10.1016\/j.vaccine.2022.04.031_b0060","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.15585\/mmwr.mm695152e2","article-title":"The Advisory Committee on Immunization Practices\u2019 Updated Interim Recommendation for Allocation of COVID-19 Vaccine \u2014 United States, December 2020","volume":"69","author":"Dooling","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.vaccine.2022.04.031_b0065","unstructured":"CDC. Considerations involving pregnancy, lactation, and fertility. https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fcovid-19%2Finfo-by-product%2Fclinical-considerations.html#pregnant Accessed January 23, 2022"},{"key":"10.1016\/j.vaccine.2022.04.031_b0070","unstructured":"Shimabukuro TT, Kim SY, Myers TR, et al.. Preliminary Findings of mRNA COVID-19 Vaccine Safety in Pregnant Persons. N Engl J Med. 2021 Apr 21:NEJMoa2104983. 10.1056\/NEJMoa2104983. Epub ahead of print. PMID: 33882218; PMCID: PMC8117969."},{"key":"10.1016\/j.vaccine.2022.04.031_b0075","unstructured":"CDC. V-safe COVID-19 Vaccine Pregnancy Registry. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/vsafepregnancyregistry.html Accessed January 23, 2022"},{"issue":"36","key":"10.1016\/j.vaccine.2022.04.031_b0080","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.031_b0085","unstructured":"Medical dictionary for regulatory activities. https:\/\/www.meddra.org\/"},{"key":"10.1016\/j.vaccine.2022.04.031_b0090","unstructured":"21 CFR Part 600.80. Postmarketing reporting of adverse experiences. Fed Regist1997. p. 52252-3"},{"issue":"5","key":"10.1016\/j.vaccine.2022.04.031_b0095","doi-asserted-by":"crossref","first-page":"473.e1","DOI":"10.1016\/j.ajog.2011.06.047","article-title":"Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System","volume":"205","author":"Moro","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.031_b0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system","volume":"53","author":"Dumouchel","year":"1999","journal-title":"Am Stat."},{"issue":"6","key":"10.1016\/j.vaccine.2022.04.031_b0105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA\u2019s spontaneous reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf."},{"key":"10.1016\/j.vaccine.2022.04.031_b0110","unstructured":"Provisional data from the National Vital Statistics System, National Center for Health Statistics, CDC. Monthly and 12 month-ending number of live births, deaths and infant deaths: United States. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/provisional-tables.htm Accessed January 23, 2022"},{"key":"10.1016\/j.vaccine.2022.04.031_b0115","unstructured":"Vital Statistics Online Data Portal. https:\/\/www.cdc.gov\/nchs\/data_access\/vitalstatsonline.htm Accessed January 23, 2022"},{"key":"10.1016\/j.vaccine.2022.04.031_b0120","unstructured":"User Guide to the 2019 Fetal Death Public Use File https:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/Dataset_Documentation\/DVS\/fetaldeath\/2019FetalUserGuide.pdf Accessed January 23, 2022"},{"issue":"24","key":"10.1016\/j.vaccine.2022.04.031_b0125","doi-asserted-by":"crossref","first-page":"895","DOI":"10.15585\/mmwr.mm7024e2","article-title":"COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy \u2014 Eight Integrated Health Care Organizations, United States, December 14, 2020\u2013May 8, 2021","volume":"70","author":"Razzaghi","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.031_b0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ajog.2019.07.036","article-title":"Amniotic fluid embolism: principles of early clinical management","volume":"222","author":"Pacheco","year":"2020","journal-title":"Am J Obstet Gynecol."},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.031_b0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.04.031_b0140","unstructured":"CDC. Pregnancy mortality surveillance. Pregnancy Mortality Surveillance System | Maternal and Infant Health | CDC Accessed January 23, 2022"},{"key":"10.1016\/j.vaccine.2022.04.031_b0145","unstructured":"CDC. Mortality in the United States, 2019. NCHS Data Brief, Number 395, December 2020 (cdc.gov) Accessed January 23, 2022"},{"issue":"28","key":"10.1016\/j.vaccine.2022.04.031_b0150","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1016\/j.vaccine.2021.05.016","article-title":"U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines","volume":"39","author":"Gubernot","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.031_b0155","doi-asserted-by":"crossref","unstructured":"Zauche LH, Wallace B, Smoots AN, et al. CDC v-safe Covid-19 Pregnancy Registry Team. Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion. N Engl J Med. 2021 Sep 8. 10.1056\/NEJMc2113891. Epub ahead of print. PMID: 34496196.","DOI":"10.1097\/01.aoa.0000853576.38395.da"},{"key":"10.1016\/j.vaccine.2022.04.031_b0160","unstructured":"Kharbanda EO, Haapala J, DeSilva M, et al. Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy. JAMA. 2021 Sep 8. 10.1001\/jama.2021.15494. Epub ahead of print. PMID: 34495304.https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2784193?resultClick=1 Accessed January 23, 2022"},{"key":"10.1016\/j.vaccine.2022.04.031_b0165","unstructured":"Hamilton et al. Births: Provisional data for 2020. Vital Statistics Rapid Release; no 12. Hyattsville, MD: National Center for Health Statistics. May 2021. 10.15620\/cdc:104993 Accessed January 23, 2022"},{"key":"10.1016\/j.vaccine.2022.04.031_b0170","doi-asserted-by":"crossref","unstructured":"Moro PL, Tepper NK, Grohskopf LA, Vellozzi C, Broder K. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy. Expert Rev Vaccines. 2012 Aug;11(8):911-21. 10.1586\/erv.12.72. PMID: 23002972.","DOI":"10.1586\/erv.12.72"},{"key":"10.1016\/j.vaccine.2022.04.031_b0175","series-title":"Harrison's Principles of Internal Medicine, 19e New York","year":"2014"},{"key":"10.1016\/j.vaccine.2022.04.031_b0180","doi-asserted-by":"crossref","unstructured":"Rosenblum HG, Hadler SC, Moulia D, et al. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices \u2014 United States, July 2021. MMWR Morb Mortal Wkly Rep 2021;70:1094-1099. 10.15585\/mmwr.mm7032e4","DOI":"10.15585\/mmwr.mm7032e4"},{"issue":"27","key":"10.1016\/j.vaccine.2022.04.031_b0185","doi-asserted-by":"crossref","first-page":"977","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices \u2014 United States, June 2021","volume":"70","author":"Gargano","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:14:36Z","timestamp":1759403676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22004479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":37,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0264410X22004479"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 \u2013 October 2021","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}